{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/sec/admin/check?name=Howard%20B.%20Schiller","name":"Howard B. Schiller","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.sec.gov/litigation/admin","generated_at":"2026-09-25T05:40:45.566Z"},"count":5,"matches":[{"release_number":"33-10811, 34-89444","release_act":"33","file_number":"3-19901","publish_date":"2020-07-31","respondents":"Howard B. Schiller","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2020/33-10811.pdf","canonical_url":"https://api.ai-analytics.org/sec-admin/33-10811%2C%2034-89444"},{"release_number":"34-99284","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard B. Schiller, Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99284.pdf","canonical_url":"https://api.ai-analytics.org/sec-admin/34-99284"},{"release_number":"34-99468","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies, Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99468.pdf","canonical_url":"https://api.ai-analytics.org/sec-admin/34-99468"},{"release_number":"34-99516","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies, Inc.,; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99516.pdf","canonical_url":"https://api.ai-analytics.org/sec-admin/34-99516"},{"release_number":"34-100808","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-100808.pdf","canonical_url":"https://api.ai-analytics.org/sec-admin/34-100808"}]}